category,datetime,headline,id,image,related,source,summary,url
company,1768417757,How Investors Are Reacting To Danaher (DHR) Upbeat 2025 Outlook And Growing Synthetic Biology Ambitions,138114761,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,DHR,Yahoo,"In early January 2026, Danaher announced ahead of the J.P. Morgan Healthcare Conference that it expects fourth-quarter 2025 revenue and full-year non-GAAP adjusted diluted EPS to finish toward the upper end of prior guidance, backed by solid bioprocessing, life sciences, and diagnostics performance. A separate update from Danaher company Integrated DNA Technologies highlighted a new collaboration with Ansa Biotechnologies, expanding access to longer, more complex DNA constructs and...",https://finnhub.io/api/news?id=b568dacc34c1c001b94c9451da04bb35e199238a3a3fadc12ea1f3748ac0332c
company,1768416268,JPM26: Danaher positioned to improve patient diagnostics,138114762,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,DHR,Yahoo,"Danaher anticipates a strong 2026 due to its diagnostic portfolio being in highly attractive areas such as molecular testing, pathology and blood gas, and in core lab.",https://finnhub.io/api/news?id=cd544a9a45286781caedef386bdf459ec0d33119a84103a02231f6bebc8e11e6
company,1768408560,Danaher Corp. stock underperforms Wednesday when compared to competitors despite daily gains,138126376,,DHR,MarketWatch,Danaher Corp. stock underperforms Wednesday when compared to competitors despite daily gains,https://finnhub.io/api/news?id=cf7203ded9dde741d8982f46503eb693db71fe6d77dcf4e3abe94c7ae2236ed6
company,1768395900,Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products,138111266,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,DHR,Yahoo,"SUNNYVALE, Calif. & EMERYVILLE, Calif., January 14, 2026--IDT and Ansa are joining forces to empower customers with sequence-perfect constructs up to 50 kb, expanding IDT's synthetic biology portfolio.",https://finnhub.io/api/news?id=36ca5a8a096277cdcbf84b5790acde0cebe7bfaffb71266ce7f2a2e4800611c2
company,1768395439,Danaher (DHR) Rebounded on Accelerated Demand,138111267,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,DHR,Yahoo,"Mar Vista Investment Partners, LLC, an investment management company, released its “Mar Vista U.S. Quality Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. US equities experienced a strong momentum in 2025 and marked their second consecutive year of double-digit gains. The market witnessed one of the fastest recoveries following its […]",https://finnhub.io/api/news?id=12478f0460ff03724476171997d9f9f2cd81b6ccae1e014eec199dac54af3b99
